Medicare Enrolled

Dr. David Baumgarten, MD

Pulmonary Disease · Cherry Hill, NJ
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
107 BERLIN RD, Cherry Hill, NJ 08034
8564291800
In practice since 2013 (13 years)
NPI: 1770920720 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Baumgarten from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Baumgarten? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Baumgarten

Dr. David Baumgarten is a pulmonary disease specialist in Cherry Hill, NJ, with 13 years of NPI registration. Based on federal Medicare data, Dr. Baumgarten performed 2,468 Medicare services across 1,455 unique beneficiaries.

Between the years covered by Open Payments, Dr. Baumgarten received a total of $4,554 from 28 pharmaceutical and/or device companies across 248 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Baumgarten is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 13 years in practice ▲ Top 25% volume in NJ $4,554 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,468
Medicare services
Top 25% in NJ for pulmonary disease
1,455
Unique beneficiaries
$93
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~190 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
801 $67 $163
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
446 $101 $244
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
318 $104 $284
Critical care, first 30-74 min
Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient.
222 $181 $596
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
132 $110 $291
Pulmonary gas exchange test
A test to examine how well the lungs exchange gases.
95 $51 $185
Lung volume test using gas dilution or washout
A test that measures the amount of air in your lungs by using a gas dilution or washout method.
90 $39 $145
Expiratory airflow and volume test
A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume.
86 $24 $120
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
69 $153 $395
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
68 $147 $430
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
51 $131 $365
Spirometry test before and after medication
A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication.
34 $34 $200
Exercise-induced lung stress test
A test performed to evaluate how the lungs function during physical exertion. It helps identify breathing difficulties or lung conditions that occur specifically when exercising.
21 $29 $110
Hospital discharge management, 30+ min
This service covers the care provided by a physician or qualified healthcare professional on the day a patient is discharged from the hospital. It requires more than 30 minutes of total time spent on the day of discharge.
18 $98 $244
Smoking cessation counseling, more than 10 minutes
Intensive counseling session focused on helping patients quit smoking and tobacco use, lasting more than 10 minutes.
17 $28 $61
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$4,554
Total received (2019-2024)
Avg $759/year across 6 years
Top 33% in NJ for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
28
Companies
248
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,439 (97.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$115 (2.5%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,529
2023
$1,148
2022
$1,239
2021
$461
2020
$37
2019
$141

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$470
GlaxoSmithKline, LLC.
$449
GENZYME CORPORATION
$119
Regeneron Healthcare Solutions, Inc.
$97
JAZZ PHARMACEUTICALS INC.
$77
Philips North America LLC
$68
Actelion Pharmaceuticals US, Inc.
$51
ABIOMED
$51
Mylan Specialty L.P.
$47
Bayer Healthcare Pharmaceuticals Inc.
$36
HARMONY BIOSCIENCES LLC
$17
Takeda Pharmaceuticals U.S.A., Inc.
$17
Genentech USA, Inc.
$16
Amgen Inc.
$15
Top 3 companies account for 67.9% of 2024 payments
All-time payments by company (2019-2024) ›
AstraZeneca Pharmaceuticals LP
$1,325
GlaxoSmithKline, LLC.
$1,022
Regeneron Healthcare Solutions, Inc.
$579
GENZYME CORPORATION
$291
Philips Electronics North America Corporation
$188
Boehringer Ingelheim Pharmaceuticals, Inc.
$152
Genentech USA, Inc.
$147
Mylan Specialty L.P.
$96
Actelion Pharmaceuticals US, Inc.
$95
Amgen Inc.
$83
JAZZ PHARMACEUTICALS INC.
$77
Harmony Biosciences LLC
$69
Philips North America LLC
$68
ABIOMED
$51
Novartis Pharmaceuticals Corporation
$40
Bayer Healthcare Pharmaceuticals Inc.
$36
Takeda Pharmaceuticals U.S.A., Inc.
$34
Jazz Pharmaceuticals Inc.
$32
Teva Pharmaceuticals USA, Inc.
$28
Insmed, Inc.
$27
HARMONY BIOSCIENCES LLC
$17
Pulmonx Corporation
$16
Allergan Inc.
$15
Merck Sharp & Dohme Corporation
$14
IDORSIA PHARMACEUTICALS US INC
$14
Janssen Pharmaceuticals, Inc
$14
Grifols USA, LLC
$14
E.R. Squibb & Sons, L.L.C.
$11
Top 3 companies account for 64.3% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · (AK6) Vest Therapy · AIRSUPRA · ANORO ELLIPTA · ARALAST · AREXVY · AVYCAZ · Adempas · AirDuo Digihaler · Arikayce · BELSOMRA · BREZTRI · BREZTRI AEROSPHERE · CHARTIS CATHETER · DUPIXENT · ELIQUIS · Esbriet · FASENRA · Impella · NUCALA · OFEV · OPSUMIT · Prolastin-C Liquid · QUVIVIQ · STIOLTO RESPIMAT · SYMBICORT · TEZSPIRE · TRELEGY ELLIPTA · UPTRAVI · WAKIX · Wakix · XARELTO · XOLAIR · XYWAV · Xolair · YUPELRI · Yupelri
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a pulmonary disease specialist in Cherry Hill?
Compare pulmonary diseases in the Cherry Hill area by procedure volume, costs, and industry payment transparency.
Browse pulmonary diseases nearby

Geographic Context

Pulmonary diseases within 10 mi
275
Per 100K population
52.5
County median income
$86,384
Nearest hospital
WEST JERSEY HOSPITAL
4.7 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Baumgarten is a clinical cardiology specialist, with above-average Medicare volume (top 25% in NJ), with low-engagement industry engagement.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Baumgarten experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Baumgarten performed 801 hospital follow-up visit, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Baumgarten receive payments from pharmaceutical companies?
Yes. Dr. Baumgarten received a total of $4,554 from 28 companies across 248 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Baumgarten's costs compare to other pulmonary diseases in Cherry Hill?
Dr. Baumgarten's average Medicare payment per service is $93. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Baumgarten) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →